Clinical Trial

Effect of Enamel Cleaning on a Remineralizing Paste for Hypomineralizated Lesions

Study acronym: ECLIPSE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Molar-incisor hypomineralization (MIH) is a qualitative defect of dental enamel, in which low mineral content and high protein content compromise the effectiveness of remineralizing treatments. Various agents have been used to remove proteins from hypomineralized enamel, such as sodium hypochlorite (NaOCl). Sodium hypochlorite is an antimicrobial irrigant capable of dissolving tissues. The amorphous calcium fluoride casein phosphate phosphopeptide (CPP-ACPF) is used as a remineralizing agent for MIH lesions, it is capable of stabilizing calcium, phosphate, and fluoride ions on the tooth surface, maintaining them in an amorphous form. Therefore, the objective of this study is to evaluate the clinical performance of CPP-ACPF dental mousse on deproteinized hypomineralized enamel.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-11.
Trial Details
NCT Number NCT07653373
Lead Sponsor Universidade Ceuma
Collaborators: Fundação de Amparo à Pesquisa e Desenvolvimento Científico do Maranhão
Conditions Molar Incisor Hypomineralization
Enrollment 54 participants
Start Date 2026-08
Primary Completion 2027-12 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-08